| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Cyclin-dependent kinase 4 (CDK4) from ORIGENE TECHNOLOGIES | LY400021 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 7 (CDK7) from ORIGENE TECHNOLOGIES | LY419742 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 8 (CDK8) from ORIGENE TECHNOLOGIES | LY400507 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 1 (CDK1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400676 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 12 (CDK12), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413944 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 12 (CDK12), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429450 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 13 (CDK13), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410606 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 16 (CDK16), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401869 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 16 (CDK16), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409781 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 16 (CDK16), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429842 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 16 (CDK16), transcript variant 3 from ORIGENE TECHNOLOGIES | LY433293 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 17 (CDK17), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400928 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 17 (CDK17), transcript variant 2 from ORIGENE TECHNOLOGIES | LY433226 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 18 (CDK18), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403955 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 18 (CDK18), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403954 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 18 (CDK18), transcript variant 3 from ORIGENE TECHNOLOGIES | LY419212 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 18 (CDK18), transcript variant 3 from ORIGENE TECHNOLOGIES | LY429112 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 2 (CDK2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY419741 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 2 (CDK2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409442 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 20 (CDK20), transcript variant 1 from ORIGENE TECHNOLOGIES | LY405956 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 20 (CDK20), transcript variant 2 from ORIGENE TECHNOLOGIES | LY415970 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 20 (CDK20), transcript variant 3 from ORIGENE TECHNOLOGIES | LY421833 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 5 (CDK5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401536 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 5 (CDK5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY431225 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 6 (CDK6), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400506 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 6 (CDK6), transcript variant 2 from ORIGENE TECHNOLOGIES | LY428809 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 10 (CDK10), transcript variant a from ORIGENE TECHNOLOGIES | LY409345 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase 10 (CDK10), transcript variant b from ORIGENE TECHNOLOGIES | LY409344 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1 from ORIGENE TECHNOLOGIES | LY400022 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 4 from ORIGENE TECHNOLOGIES | LY409229 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 4 from ORIGENE TECHNOLOGIES | LY429923 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 5 from ORIGENE TECHNOLOGIES | LY434008 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409213 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417638 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409193 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429931 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) from ORIGENE TECHNOLOGIES | LY401318 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 3 (CDKN3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417450 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 3 (CDKN3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427288 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C), transcript variant 1 from ORIGENE TECHNOLOGIES | LY420041 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409196 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C), transcript variant 2 from ORIGENE TECHNOLOGIES | LY429933 | 100 ug | ORIGENE TECHNOLOGIES |
| Cyclin-dependent kinase inhibitor 1C (p57, Kip2) (CDKN1C), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424941 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807397 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS807398 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS808380 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS808381 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS609540 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS621368 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Artery: peripheral; Atherosclerosis from ORIGENE TECHNOLOGIES | CS624428 | 5x5um | ORIGENE TECHNOLOGIES |